World Conference on Lung Cancer 2023 – LuCE participation
LuCE will be actively participating in the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer #WCLC23 to be held in Singapore from 9-12 September 2023....
View ArticleUpcoming webinar “Coping with lung cancer diagnosis: Physical, social and...
Join us for our upcoming webinar on "Coping with lung cancer diagnosis: Physical, social and emotional impact". 🗓️ Date: 18 September 2023. ⏰ Time: 1-2 PM CET. 📍 Location: Online: LuCE social media...
View Article‘Get Tested!’ 2023 Public Awareness Campaign
Lung Cancer Europe (LuCE) is proud to announce that together with 23 of its Member Organisations, they unite in a public lung cancer awareness campaign which launches today and will span the month of...
View ArticleMembers Meeting 2023 in Lisbon: Where ideas were generated!
The members of LuCE came together for a highly productive and interactive Members Meeting in Lisbon on Friday & Saturday. As ever, the meeting was a great opportunity to reconnect, exchange ideas,...
View ArticleBest Advocacy Initiative: Athena.Women Against Cancer
During our Members Meeting 2023, 11 members presented their advocacy initiatives where they shared their goals, projects and accomplishments. With an overwhelming number of votes, the best initiative...
View ArticleIntroducing our newest Member: Lungunion Austria
The Lungunion Austria is a patient organization (NGO and self-aid organization) for people with airway diseases, aligned skin diseases, and allergy. They have also been representing people with lung...
View ArticleHighlights of ESMO Congress 2023
October 20th-24th in Madrid, Spain Our president Anne-Marie Baird had an active participation at the ESMO Congress as a speaker/chair. Our board members Erika Pataki, Lavinia Magee, Ewelina Szmytke,...
View ArticleRemembering Marjo Forsblom
We are very sad to share the heartbreaking news that Marjo Forsblom passed away on Sunday October 22nd 2023. Marjo was a beautiful shining light in our community. May she rest in peace. Marjo was a...
View ArticleLuCE attending the European Medicines Agency (EMA) in Amsterdam
November 14th – 15th in Amsterdam We are delighted to announce that Lung Cancer Europe (LuCE) is participating in a two-day meeting at the European Medicines Agency (EMA) in Amsterdam for Patient and...
View Article8th LuCE Report on Lung Cancer: Launch Event
We are delighted to present the 8th Report, titled “Financial impact of lung cancer: A European Perspective”. Lung Cancer Europe will hold an event on 29th November at the European Parliament...
View Article8th Edition of the LuCE Report – Financial impact of lung cancer: A European...
This is an annual initiative led by lung cancer patient organisations, across Europe with the purpose of raising awareness relating to the main challenges faced by people impacted by this disease. This...
View ArticlePress Release: High risk of financial vulnerability after diagnosis: The...
Financial impact of lung cancer: A European perspective Brussels, November 29th, 2023 – Lung Cancer Europe (LuCE) today launched the 8th LuCE Report entitled ‘Financial impact of lung cancer: A...
View ArticleBMS Press Release is out now
Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib is a...
View Article
